152 related articles for article (PubMed ID: 11803162)
1. Role of inflammation and its treatment in ESRD patients.
Kaysen GA
Blood Purif; 2002; 20(1):70-80. PubMed ID: 11803162
[TBL] [Abstract][Full Text] [Related]
2. Inflammation in end-stage renal failure: could it be treated?
Stenvinkel P
Nephrol Dial Transplant; 2002; 17 Suppl 8():33-8; discussion 40. PubMed ID: 12147775
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory cytokines and malnutrition as related to risk for cardiovascular disease in hemodialysis patients.
Perunicic-Pekovic G; Pljesa S; Rasic-Milutinovic Z; Stankovic S; Ilic M; Maletic R
Can J Physiol Pharmacol; 2008 Apr; 86(4):205-9. PubMed ID: 18418430
[TBL] [Abstract][Full Text] [Related]
4. [Chronic inflammation and cardiovascular risk in hemodialysis].
Pertosa G; Simone S; Soccio M; Marrone D; Grandaliano G
G Ital Nefrol; 2003; 20(6):631-40. PubMed ID: 14732917
[TBL] [Abstract][Full Text] [Related]
5. IL-18 is involved in vascular injury in end-stage renal disease patients.
Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
[TBL] [Abstract][Full Text] [Related]
6. Approaches to the reversal of malnutrition, inflammation, and atherosclerosis in end-stage renal disease.
Caglar K; Hakim RM; Ikizler TA
Nutr Rev; 2002 Nov; 60(11):378-87. PubMed ID: 12462522
[TBL] [Abstract][Full Text] [Related]
7. [Predictors of mortality in dialysis patients--association between malnutrition, inflammation and atherosclerosis (MIA syndrome)].
Perunicić-Peković G; Rasić-Milutinović Z; Pljesa S
Med Pregl; 2004; 57(3-4):149-52. PubMed ID: 15462598
[TBL] [Abstract][Full Text] [Related]
8. [Malnutrition, inflammation and atherosclerosis (MIA-syndrome) in dialysis patients].
de Mutsert R; Krediet RT
Ned Tijdschr Geneeskd; 2006 Sep; 150(37):2023-7. PubMed ID: 17058458
[TBL] [Abstract][Full Text] [Related]
9. [Strong connection between malnutrition, inflammation and arteriosclerosis. Improved treatment of renal failure if underlying factors are attacked].
Efendic E; Lindholm B; Bergström J; Stenvinkel P
Lakartidningen; 1999 Oct; 96(42):4538-42. PubMed ID: 10575860
[TBL] [Abstract][Full Text] [Related]
10. Inflammation in end-stage renal disease--what have we learned in 10 years?
Carrero JJ; Stenvinkel P
Semin Dial; 2010; 23(5):498-509. PubMed ID: 21039875
[TBL] [Abstract][Full Text] [Related]
11. The role of oxidative stress-altered lipoprotein structure and function and microinflammation on cardiovascular risk in patients with minor renal dysfunction.
Kaysen GA; Eiserich JP
J Am Soc Nephrol; 2004 Mar; 15(3):538-48. PubMed ID: 14978155
[TBL] [Abstract][Full Text] [Related]
12. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
[TBL] [Abstract][Full Text] [Related]
13. Inflammation in ESRD: causes and potential consequences.
Kaysen GA; Kumar V
J Ren Nutr; 2003 Apr; 13(2):158-60. PubMed ID: 12671842
[TBL] [Abstract][Full Text] [Related]
14. Gene polymorphism association studies in dialysis: the nutrition-inflammation axis.
Stenvinkel P; Pecoits-Filho R; Lindholm B;
Semin Dial; 2005; 18(4):322-30. PubMed ID: 16076356
[TBL] [Abstract][Full Text] [Related]
15. [Malnutrition -- inflammation -- atherosclerosis (MIA syndrome) in patients with renal failure].
Pawlaczyk K; Oko A; Lindholm B; Czekalski S
Pol Merkur Lekarski; 2003 Oct; 15(88):334-41; discussion 341-3. PubMed ID: 14974361
[TBL] [Abstract][Full Text] [Related]
16. Characteristics and effects of inflammation in end-stage renal disease.
Kaysen GA; Eiserich JP
Semin Dial; 2003; 16(6):438-46. PubMed ID: 14629602
[TBL] [Abstract][Full Text] [Related]
17. Inflammation, malnutrition, cardiovascular disease and mortality in end-stage renal disease.
Bergström J
Pol Arch Med Wewn; 2000 Oct; 104(4):641-3. PubMed ID: 11392151
[No Abstract] [Full Text] [Related]
18. Inflammation in end-stage renal disease: sources, consequences, and therapy.
Stenvinkel P; Alvestrand A
Semin Dial; 2002; 15(5):329-37. PubMed ID: 12358637
[TBL] [Abstract][Full Text] [Related]
19. Malnutrition and chronic inflammation as risk factors for cardiovascular disease in chronic renal failure.
Stenvinkel P
Blood Purif; 2001; 19(2):143-51. PubMed ID: 11150801
[No Abstract] [Full Text] [Related]
20. Clinical value of the malnutrition-inflammation-atherosclerosis syndrome for long-term prediction of cardiovascular mortality in patients with end-stage renal disease: a 5-year prospective study.
Akdag I; Yilmaz Y; Kahvecioglu S; Bolca N; Ercan I; Ersoy A; Gullulu M
Nephron Clin Pract; 2008; 108(2):c99-c105. PubMed ID: 18212491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
